Answers are grounded in this paper and cite their sources.
Life-cycle effects of a reference ecdysteroid, 20-hydroxyecdysone (20-HEC) and the model xenoestrogen, diethylstil-bestrol (DES) in Tisbe battagliai (Crustacea, Copepoda, Harpacticoida) have been evaluated. T. battagliai is a sexually reproducing species that is representative of an ecologically diverse group of aquatic Crustacea and is highly amenable to laboratory life-cycle studies. Newly released (<24-h old) Copepod nauplii were exposed to 20-HEC or DES and effects monitored in terms of survival, development, and sex ratio after 10 d at 20 ± 1°C. A mortality of ≈40% occurred after 9-d exposure to 20-HEC at 269 μg/L, whereas significant (17.5%) mortality (p < 0.05) occurred after 4-d exposure to DES at 100 μg/L. Adult males and females were paired after day 10, and exposures continued to investigate effects on reproductive output (21-d total exposure). In summary, the 21-d LC50 values (with 95% confidence intervals) for 20-HEC and DES were 53.4 μg/L (36.5–78.7) and 31.6 μg/L (10–100), respectively. For 20-HEC, the 21-d no observed effect concentration (NOEC) for survival was 26.9 μg/L, whereas reproduction was a more sensitive endpoint (NOEC = 8.7 μg/L). For DES, survival and reproduction were equally sensitive, and both gave an NOEC value of 10 μg/L (all based on nominal concentrations). These results suggest that the 21-d life-cycle protocol using T. battagliai holds much promise as an in vivo test for developmental and reproductive effects in aquatic Crustacea.
No takes yet. Share an insight, caveat, or question.
Hutchinson et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: